Adam, Heather J <br/><br/>
Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Jan 2007 
 - 198-207 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.00609-06  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Aza Compounds--pharmacology<br/>Bacterial Proteins--genetics<br/>Canada--epidemiology<br/>Child<br/>Child, Preschool<br/>Ciprofloxacin--pharmacology<br/>Drug Resistance, Bacterial--genetics<br/>Electrophoresis, Gel, Pulsed-Field<br/>Fluoroquinolones--pharmacology<br/>Gatifloxacin<br/>Gemifloxacin<br/>Genotype<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Levofloxacin<br/>Middle Aged<br/>Moxifloxacin<br/>Naphthyridines--pharmacology<br/>Ofloxacin--pharmacology<br/>Pneumococcal Infections--epidemiology<br/>Quinolines--pharmacology<br/>Serotyping<br/>Streptococcus pneumoniae--classification